| Date | Title | Description |
| 09.02.2023 | Mineralys Therapeutics Announces Pricing of Upsized Initial ... | The offering is expected to close on February 14, 2023, subject to the satisfaction of customary clo... |
| 24.01.2023 | Aculys Pharma Initiates a Phase 3 Trial of pitolisant Treati... | This trial is a multi-center, randomized, double-blind, placebo-controlled, parallel-group study (Pa... |
| 18.01.2023 | Pathalys Pharma Raises $150 Million in Secured Product Finan... | Research Triangle Park, North Carolina and Boston, Massachusetts, January 18, 2023 — Pathalys Pharma... |
| 08.01.2023 | Phathom Pharmaceuticals Announces Positive Topline Results f... | FLORHAM PARK, N.J., Jan. 08, 2023 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a... |
| 10.11.2022 | Aculys Pharma initiates a phase 3 clinical study of a diazep... | This phase 3 study, conducted in Japan, is a multi-center, open-label study in children with status ... |
| 08.11.2022 | Aculys Pharma initiates a phase 3 clinical study of the hist... | This phase 3 study consists of a multi-institutional double-blind, randomized, placebo-controlled, p... |
| 03.05.2022 | Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ ... | FLORHAM PARK, N.J., May 03, 2022 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a ... |
| 03.05.2022 | HilleVax Announces Closing of Initial Public Offering and Fu... | Registration statements relating to the offering have been filed with the Securities and Exchange Co... |
| 02.05.2022 | HilleVax Announces Initiation of Phase 2b Clinical Trial of ... | The clinical trial is a Phase 2b, randomized, double-blind, placebo-controlled study to evaluate the... |
| 30.03.2022 | Phathom Pharmaceuticals Submits Vonoprazan NDA to FDA for th... | Erosive esophagitis, a major type of gastroesophageal reflux disease (GERD), affects approximately 2... |
| 28.03.2022 | Aculys Pharma Closes US$24 Million Series B Financing | Kazunari Tsunaba, Co-founder, Chief Executive Officer and Representative Director of Aculys said, “A... |
| 23.03.2022 | Catalys Pacific Launches Kirilys Therapeutics as a Multi-ass... | KRLS-017 is a reversible small molecule inhibitor of Cyclin Dependent Kinase 7 (CDK7). CDK7 has been... |
| 02.03.2022 | Pathalys Pharma, Inc. Launches with Mission to Address High ... | “We are excited about this opportunity to join forces with DaVita, a recognized leader in kidney car... |
| 17.02.2022 | Catalys Pacific Adds Experienced Pharmaceutical Executive to... | Prior to Liquidia, Neal worked for seven years with Johnson and Johnson, serving as President of Cen... |
| 17.02.2022 | Catalys Pacific Adds Experienced Pharmaceutical Executives t... | Prior to Liquidia, Neal worked for seven years with Johnson and Johnson, serving as President of Cen... |
| 04.02.2022 | Aculys Pharma Initiated a Phase 1 Clinical Trial of pitolisa... | Aculys Pharma has an exclusive licensing agreement for the clinical development and commercializatio... |
| 26.01.2022 | Aculys Pharma signed an exclusive licensing agreement with N... | Aculys Pharma, Inc. (“Aculys Pharma” Headquarters: Fujisawa City, Kanagawa Prefecture, Representativ... |
| 29.10.2021 | Aculys Pharma Closes US$60 Million Series A Financing Led by... | “We are delighted to partner with Bioprojet to advance the development of pitolisant, a therapeutic ... |
| 18.10.2021 | Phathom Pharmaceuticals Announces Positive Topline Results f... | FLORHAM PARK, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a... |
| 04.10.2021 | Catalys Pacific Strengthens Company Creation Team with New O... | Prior to Novartis, he served as General Manager for Australia, New Zealand, and Hong Kong as well as... |
| 08.09.2021 | Phathom Pharmaceuticals Submits Two NDAs to U.S. FDA for Von... | With current standard of care therapies, H. pylori eradication rates have declined in the U.S. If ap... |
| 08.09.2021 | HilleVax Closes $135 Million Crossover Financing to Advance ... | Boston, Mass., September 8, 2021 – HilleVax, Inc. (HilleVax), a biopharmaceutical company focused on... |
| 09.08.2021 | Remembering Catalys Pacific Industry Advisor Tadataka ‘Tachi... | Tachi spent his life traveling between Japan and the United States as a student, physician, academic... |
| 29.04.2021 | Phathom Pharmaceuticals Announces Positive Topline Results f... | FLORHAM PARK, N.J., April 29, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), ... |
| 06.04.2021 | Mineralys Therapeutics Closes $40 Million Series A Funding | Aldosterone has been implicated as an underlying cause of hypertension in upwards of 30 percent of a... |
| 19.01.2021 | Phathom Pharmaceuticals Announces Completion of Patient Enro... | PHALCON-HP is a randomized, multicenter, Phase 3 trial that has enrolled over 1,000 patients with H.... |
| 30.11.2020 | Phathom Pharmaceuticals Announces Completion of Patient Enro... | PHALCON-EE is a randomized, double-blind, two-phase, multicenter Phase 3 trial that has enrolled ove... |
| 04.11.2020 | Catalys Pacific Strengthens Company Creation Team with New O... | In addition to working for Catalys Pacific, he currently serves as Chairman of The Christopher and D... |
| 16.07.2020 | Domain Associates and Catalys Pacific Launch Exalys Therapeu... | The new company is focused on the development of first-in-class therapies for the treatment of infla... |
| 19.06.2020 | Catalys Pacific Strengthens Company Creation Team with New I... | As CEO of Kyowa Kirin, he led the development and launch of a series of innovative drugs including m... |
| 09.12.2019 | Catalys Pacific Strengthens Company Creation Team with New O... | From 2015 through 2019, Hito worked as President, CEO and CTO of PHC Holdings Corporation (formerly ... |
| 24.10.2019 | Phathom Pharmaceuticals Announces Pricing of Initial Public ... | The shares are expected to begin trading on the Nasdaq Global Select Market on October 25, 2019 unde... |
| 23.07.2019 | Japanese Foreign Minister’s Commendations for FY 2019 to Dr.... | Foreign Minister’s Commendations are awarded to individuals and groups with outstanding achievements... |
| 17.06.2019 | Catalys Pacific Launches in Japan to Advance Early-Stage Lif... | - |
| 14.05.2019 | Takeda and Frazier Healthcare Partners Announce Collaboratio... | - |
| 27.04.2019 | Ito Review 2.0: Biotech Edition | - |
| 01.04.2019 | Recida Therapeutics Announces the Initiation of a Phase I Cl... | - |
| 01.01.2019 | 2019 Silicon Valley Bank Annual Report | - |
